 

uum : iggﬁ’ﬁﬁéﬁ'afﬁfﬁisg- Fisssasiigt'ﬁﬁﬁﬁilt e d

llllIllllIIIlllllllllllllllIlillllllllllllllllllllllll
I II III!
i"liiiilliimmImullliiiiliiiiiiiiilliiiiliilllluIll

 

ll 1 IIIIIIHIIIIIIIH J" awe 8
I ﬂ .1: ~—
Chmcal Case Report 6 - M
(For Coiiection of Cancerous Tissue) a u ’ ‘ N06
”“9” 52/3
SAL C ' m,
a , £1.55 (£53.67
[Informed Consenii 9W dial/‘3
I personally informed this patient that a specimen(s) wouid be collected to be used for research
purposes. I reviewed the ESEARCH SUBJECT INFORMATION AND CONSENT

FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

 

ﬁame of Physician hr Study Coordinate?“ Signatute I Date

 

Minical Informationi

GENERAL INFORMA ON

 

 

 

 

(mm!
(3 Single ‘
’ Gender ‘ i D Divorced D Widow stood Pressure Heart Rate
0 Male emale
HISTORY OF PRESENT ILLNESS
Chief Complaints: [Wévwfﬂm
Symptoms: (i, Lt gab/~71 yﬂWﬁ/M 32"” Z Wuwm

 

Ciinical Findings: Veal,va ( wakmp w w»? yew wwé . Mommy/c"
(M [201+~M"ev cw vim/C Lip ,« CL 'YLtf/i’ E.) Lil/31% new” thing ‘
Performance Scale (Karnofsky Score):

{3 100 Asymptomatic @8090 Symptomatic but Fully Ambulatory D 60~70 Symptomatic, in bed less than 50% of day
1:} 40‘50 Symptomatic, in bed more than 50% ofday, but not bed ridden c3 20-30 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Dose

 

PAST MEDICAL HISTORY
Disorder

Date Treatment

 

 

 

 

 

 

 

 

 

 

 

OBIGYN HISTORY _
Menopausal Status Pate of First Menses # of Pregnancies
E3 Precmenopausal 2
D Peri»Mcnopausal Date of Lakt Houses # of Live Births
D Post‘menopausai WV} ﬂue, WW hem; A; 2
Birth Control: in Condom 2:: Oral Contraceptive )tLLUD I a Hormone Repiacement
D Other: Therapy: :3 a

 

SOCIAL HISTORY
Environments! Hazards:

H

Packs Duration

Alcohoi Consum
TYPE Drinks

[3 YES NO

Use
Current Status
E3 YES

Duration

FAMILY MEDICAL HISTORY

Relative

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result Date i Test Result Date

HIV Negative (:3 Positive: _ CEA E1 Negative Cl Positive: {(A7
Hep B Megative a Positive: ‘ CA 15-3 D Negative {3 Positive: LL47
Hep C [3 Negative 1:1 Positive: 1 L? CA 19—9 E} Negative D Positive: m ,4)

AFP :3 Negative [:3 Positive: :4 a PSA t3 Negative Ci Positive: ) A it
Other: C3 Negative [3 Positive: i/W Other: [:1 Negative Cl Positive; Mfg

8/? Cell Markers: MAO

 

 

DIAGNOSTIC STUDIES
Rosuits

Ultrasound
x-
CT

CLINICAL DIAGNOSIS

K

Location of Involved l. Nodes Location of Distant Metastasis

of
T N M Stage: 7‘

17 reatment Information] 21%
SURGICAL TREATMENT

 

 

Date of Procedure

Tumor
Location

~- \

of
a

Location of L Nodes # of L Nodes
Paipable, Non~Dissected Lymph Nodes

Dissected Lymph Nodes
Distant Metastasis

Detailed Location

T N M

NEOADJUVENT THERAPY
Doso

 

eathology Form

 

[Specimen Information] -_

 

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: « Date: Time:”
Preserved by: ‘ Date _Time:__
SPECIMEN TYPE (itE of samples provided)
Frozen Parafﬁn Block Blood/Semmfl’lasma Slide
Diseased Nome! Diseased Normal Diseased Normal Diseased Norma!
4 /( A 4 if 4‘
Time to LN2 Time to Formalin Time to LN2 ‘
) x/W min 3 ’5) min (7' 4; min

 

 

 

Notes:

 

PATHOLOGICAL DESCRIPTION
Tumor
Size Extension of Tumor Distance to NAT
x x cm \ ' 9: cm

Nodes
at Examined it Metastasized

Distant Metastasis
Location

 

 

Microscopic Descriptloﬁ

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Histologlgal Pattern
Cell Distribution + - Structural Pattern + -
Diffuse ' “A Streaming +
Mosaic «f Storiforrn Mf—
Necmsls «l— Fibrosis A»
Lymphocytic Inﬁltration -~r Pallsadlng .+
Vascular Invasion «v , Cystic Degeneration +
Clusterized .l Bleeding ~l
Alveolar Formation l Myxoid Change l
Indian File Psammoma/Calclﬁcation of
Cellular Differentiation
Squamous + — Adenomatous + - Sarcomatous + - Lymphomatous + -
Squamoid Cell ~l Glandular cell 9 Round Cell l“ Large Cell l
Spindle Cell ‘% Cell Stratiﬁcation + Fibroblast 4;. Small Cell +
Keratln + Secretion 4 Osteoblast l— RS Cell/RS Like 1»
Desmosome er Intracyt. Vacuole 4% Lipoblast l Inﬂam. Cell 1‘
Pearl «A: Gland formation we Myoblast 4" Plasma Cell l‘
Cellular Differentiation: Well Moderate «H Poor
Nuclear Appearance
Nuclear Atypia: O I II III
Aniso Nucleosis +~
Hyperchromatism or
Nucleolar Prominent ~+
Multlnucleated Giant Cell “'1’"
Mitotic Activity wl
Nuclear Grade: ~+
IHC Data
ER 0 Positive
PR :1 Positive
Her~ nets :1 Positive
B~Cell Marker a Positive
T~Celi Marker a Positive
Other: {3 Positive
Other: [Ii Positive
{final Pathology: Reportl
Histological Diagnosis: LC??? m fl’lleL/X (1.6 if /‘ m" Z»! l Lﬂ’le’délx
{ Grade: lg»
Comments:
Principal investigator Pathologist ....___ bate

Consolidated Pathology Diagnosis

, r—‘m

Cellular Differentiation: :3 Moderate

Nuclear O I

 

Nuclear Grade:

 

 

{ﬁnal Pathology Reporll
Histological may mis:&Wdeezm.....I’s_. ..
/l/7 : if - new é’wg

 

Comments:

Dr 3’52

 

 

 

. . , Date
Director, Research Pathology

 

